Telangana bans Almont-Kid Syrup
Analysis based on 7 articles · First reported Jan 10, 2026 · Last updated Jan 10, 2026
The recall of Almont-Kid Syrup due to Diethylene glycol adulteration will negatively impact Tridus Remedies, potentially leading to financial losses and a damaged reputation. It also highlights regulatory risks for the broader pharmaceutical industry in India, prompting stricter oversight and potentially affecting investor confidence in drug manufacturers.
The India — Drugs Control Administration, Telangana, issued an urgent advisory to immediately stop the use of Almont-Kid Syrup after it was found to be adulterated with Diethylene glycol, a highly toxic substance. This action followed an alert from the India — Central Drugs Standard Control Organisation. The affected syrup, Batch No. AL-24002, was manufactured by Tridus Remedies in India — Bihar. The India — Drugs Control Administration, Telangana, has directed all Drugs Inspectors and Assistant Directors to freeze available stocks and ensure the product is not sold or dispensed. Enforcement measures are underway, and the situation is being closely monitored to prevent public health risks. Separately, the Union Health Ministry of India has proposed stricter rules for cough syrups nationwide.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard